KPF
SRTAW

K2 Principal Fund’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

K2 Principal Fund’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-175,280
Closed -$36.8K – 415
2025
Q3 		$36.8K Sell
175,280
-321,789
-65% -$63.1K ﹤0.01% 310
2025
Q2 		$104K Buy
497,069
+20,000
+4% +$3.86K 0.01% 227
2025
Q1 		$105K Buy
477,069
+113,792
+31% +$37.8K 0.01% 255
2024
Q4 		$149K Buy
+363,277
New +$121K 0.02% 239

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

K2 Principal Fund's SRTAW Position: Q4 2025 in Review

K2 Principal Fund sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q4 2025, closing a stake of 175,280 shares — an estimated $36.8K sold.

K2 Principal Fund first reported a position in SRTAW in Q4 2024 and held it in 4 quarters. The position peaked at $149K in Q4 2024. 8 funds tracked by Wall St. Rank hold SRTAW as of Q4 2025.

  • K2 Principal Fund reported no remaining Strata Critical Medical Inc Warrants position as of Q4 2025 after selling out during the quarter.
  • K2 Principal Fund sold 175,280 Strata Critical Medical Inc Warrants shares in Q4 2025, an estimated $36.8K.
  • K2 Principal Fund first reported a position in Strata Critical Medical Inc Warrants in Q4 2024 and held it in 4 quarters.
  • K2 Principal Fund's Strata Critical Medical Inc Warrants position peaked at $149K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q4 2025.

Based on K2 Principal Fund's 13F filing for Q4 2025, filed 13 Feb 2026.